Empty Sella Is a Sign of Symptomatic Lateral Sinus Stenosis and Not Intracranial Hypertension

A. Zetchi; M.-A. Labeyrie; E. Nicolini; M. Fantoni; M. Eliezer; E. Houdart

doi:10.3174/ajnr.A6210

Abstract

BACKGROUND AND PURPOSE: Empty sella has been reported in patients with idiopathic intracranial hypertension and is thought to be a sign of elevation of intracranial pressure. However, it can also be found in patients with lateral sinus stenosis presenting with isolated pulsatile tinnitus without signs of intracranial hypertension. We hypothesized that the volume of the sella turcica would be similar in both groups of patients undergoing stent placement for lateral sinus stenosis.

MATERIALS AND METHODS: Consecutive patients with idiopathic intracranial hypertension or isolated venous pulsatile tinnitus and undergoing lateral sinus stent placement from January 2012 to December 2017 were included. The primary outcome was the estimated volume of the sella turcica based on preoperative CTA measurements. The ratio of the pituitary gland height/sellar height was calculated on preoperative MR imaging. Sellar volumes were compared among the 3 groups: pulsatile tinnitus, idiopathic intracranial hypertension, and a control group, matched by age and sex.

RESULTS: Eighty-eight patients underwent lateral sinus stent placement. The median age was 37 years, and 94% were women. No difference in age, sex, or body mass index was found among the groups. Patients undergoing venous stent placement had significantly higher sellar volumes than the control group (P < 0.001). There was no difference in the sellar volumes (P = .63) or gland/sellar height ratios (P = .25) between the pulsatile tinnitus and idiopathic intracranial hypertension groups.

CONCLUSIONS: Empty sella is found in 2 differing groups of patients undergoing lateral sinus stent placement, suggesting that it is a radiologic sign of symptomatic hemodynamic lateral sinus stenosis rather than elevated intracranial pressure.

ABBREVIATIONS:

BMI: body mass index
GH/SH: ratio of pituitary gland height/sellar height
IIH: idiopathic intracranial hypertension
IPT: isolated venous pulsatile tinnitus

Empty sella is defined as a widening of the sella turcica associated with an intrasellar arachnoidocele. Secondary forms can follow a pituitary operation or trauma.¹ Empty sella is a radiologic sign that has been described in patients with idiopathic intracranial hypertension (IIH)^2⇓⇓–5 and is often reported as a chronic consequence of the elevation of intracranial pressure.^6,7 IIH is associated with a large number of cases with lateral sinus stenosis,^8,9 which is increasingly being treated by lateral sinus stent placement.^10⇓–12 Pulsatile tinnitus may constitute 1 mode of presentation of IIH.¹³ Lateral sinus stenosis may also be revealed by pulsatile tinnitus without evidence of intracranial hypertension.^{14⇓⇓–17} When pulsatile tinnitus is disabling, stent placement for lateral sinus stenosis may be efficient for suppressing it.^18⇓–20 We therefore hypothesized that an empty sella is a consequence not of the elevation of the intracranial pressure but of the venous sinus stenosis. This stenosis, when symptomatic, may present in the form of either IIH or isolated venous pulsatile tinnitus (IPT). In the current study, we measured and compared the volumes of the sella turcica in patients with sinus stenosis revealed by IIH or IPT and treated by sinus stent placement. We compared the results of these 2 groups with those obtained in a control group of subjects free of venous sinus stenosis.

MATERIALS AND METHODS

Study Population

Consecutive patients undergoing lateral sinus stent placement from January 2012 to December 2017 were screened using a local data base and by cross-referencing it with the data base of the neuroradiology department archives. Patients with the combination of IIH or IPT and radiologic evidence of lateral venous sinus stenosis were included. IPT was defined as a pulsatile tinnitus in relation to a lateral sinus stenosis (ie, disappearing after stent placement of the stenosis) and without clinical signs of IIH. Patients with a current or past history of spontaneous or traumatic CSF leak, sellar pathology including those who underwent transphenoidal surgery, and those who presented with another potential etiology for their pulsatile tinnitus were excluded. Patients with no available preoperative and/or postoperative imaging were also excluded. Patients in whom the venous stent placement procedure failed or was not completed were also excluded. This study was approved by the institutional review board.

Data Collection

Patients' baseline demographic data and body mass index (BMI) were collected. All imaging was independently reviewed by 2 authors, one experienced neurointerventionalist (A.Z.) and a fellow in interventional neuroradiology (E.N.). Trans-stenotic gradients derived from venous manometry and the type of stenosis were also recorded. The primary outcome was defined as the estimated volume of the sella turcica based on measurements on a preoperative CTA. Maximal anterior-posterior (AP) and height (H) measurements were obtained on midsagittal 3D-MPR reconstruction. Maximal laterolateral (L) measurements were obtained on coronal 3D-MPR reconstruction (Fig 1). The volume of the sella turcica (V) was estimated on the basis of the formula for an ellipsoid volume:

Fig 1.

A 47-year-old female patient who presented with right-sided disabling pulsatile tinnitus disappearing on compression of the right jugular vein. MR imaging with an axial CISS sequence (A) shows enlargement and CSF infiltration of the sella turcica. Sagittal T1-weighted MR imaging with gadolinium shows flattening of the pituitary gland (B). Ratios of pituitary gland height/sellar height were calculated on sagittal reconstruction of a 3D gadolinium-enhanced T1 MRI sequence using the cut showing the thickest section of pituitary gland (B). Sellar volumes were estimated on the basis of dimensions measured on a preoperative CTA. The laterolateral dimension of the sella was measured on the coronal MPR of the preoperative CTA as shown in C using the longest measurement between the medial walls of the cavernous segments of the internal carotid arteries (white arrow). The sellar height and anterior-posterior diameter were measured on the 3D-MPR in the midsagittal plane as shown in D. Height was the longest measurement intersecting a line joining the tuberculum and dorsum sellae and the lowest point in the sella. The anterior-posterior measurement was defined as the longest measure on the midsagittal plane (white arrows).

The ratio of the pituitary gland height/sellar height (GH/SH) was also calculated on the basis of preoperative 3D gadolinium-enhanced T1-weighted MR imaging with sagittal reconstruction (Fig 1). The section showing the thickest pituitary gland was chosen.

Diagnosis and Treatment

Most patients were assessed and treated by our senior author (E.H.). Patients presenting with symptoms of IIH according to the modified Dandy criteria²¹ were studied by lumbar puncture with opening pressure measurements and an ophthalmologic assessment. Lumbar puncture was not performed on patients with IPT when they were free of any clinical sign of IIH, including headache, papilledema, or cranial nerve VI palsy. Patients with IIH or IPT were studied with CTA and cerebral MR imaging, including 3D-TOF, T1-weighted with gadolinium, and MRV sequences.

CT angiography was performed on Somatom Sensation 64 CT scanner (Siemens, Erlangen, Germany) using the following parameters: section thickness = 0.75 mm; 80 mAs; and 120 kV(peak) per section.

MR imaging examinations were performed on a 3T scanner (Magnetom Skyra; Siemens) with a 64-channel head-neck-spine coil after contrast media administration (0.2 mL/kg) (gadoterate megluimine, Dotarem; Guerbet, Aulnay-sous-Bois, France). We performed the 3D-TOF sequence with the following parameters: FOV = 200 × 200 mm, TR = 21 ms, TE = 3.69 ms, 384 × 278 mm, NEX = 1, and scan time = 4 minutes 40 seconds. We performed a 3D-T1 MPRAGE sequence with the following parameters: FOV = 270 × 270 mm, TR = 2000 ms, TE = 2.68 ms, 320 × 288 mm, NEX = 2, generalized autocalibrating partially parallel acquisition = 2, and scan time = 4 minutes 4 seconds. We also performed a 3D-T2 CISS sequence with the following parameters: FOV = 145 × 145 mm, TR = 6.6 ms, TE = 3.1 ms, 320 × 320 mm, flip angle = 57°, NEX = 1, and scan time = 4 minutes 30 seconds.

When stent placement of the lateral stenosis was considered, a catheter cerebral angiography was performed with the patient under local anesthesia, and pressure measurements were performed in the lateral sinus proximal and distal to the stenosis. Trans-stenotic gradient measurements were obtained by microcatheter pressure transducer manometry and Verrata fractional flow reserve piezoelectric 0.014-inch microguidewire (Philips Volcano, San Diego, California) velocity and pressure measurements. The gradient was considered high if it was equal or superior to 8 mm Hg.

Patients with confirmed IIH were first treated medically with acetazolamide and lumbar puncture. In case of refractory or recurrent symptoms after a minimum of 4 months of medical treatment, lateral sinus stent placement was proposed. We selected the dominant sinus in IIH. For IPT, disability was assessed on a visual analog scale from 0 to 10. Stent placement was proposed when the score reached or exceeded 5. In this group, venous stent placement was performed on the symptomatic side. Our technique for venous sinus stent placement has been previously described.²²

Data Analysis

Sellar volumes were compared among 3 groups: patients with IPT, patients with confirmed IIH, and a control group. The sample of control subjects comprised patients with normal findings on CTA after presentation to our emergency department, matched by age and sex. Control subjects were selected if they had no past or present intracranial pathology, no history of pulsatile tinnitus, no clinical sign of IIH, and no radiologic evidence of cerebral venous sinus stenosis. Kruskal-Wallis, ANOVA, and Dunn 2-tailed tests were used. A P value < .05 was considered statistically significant. The GH/SH and trans-stenotic gradients were compared between IPT and IIH groups using a Mann-Whitney 2-tailed test. The intraclass correlation coefficient was used to measure the interrater agreement for sellar volumes. An ANCOVA was used to test age, sex, the type of stenosis (intrinsic versus extrinsic), and BMI as potential confounding explanatory variables.

RESULTS

A total of 104 patients were screened between January 2012 and December 2017. Sixteen patients were excluded (see the flow chart in Fig 2). The median age of the 88 patients who underwent lateral sinus stent placement was 37 years (range, 20–75 years), and 94% were women. Patients' baseline characteristics are detailed in the Table. No significant difference in age or sex was noted among the 3 groups. The BMI did not differ between the 2 groups of patients with symptomatic sinus stenosis.

Fig 2.

Study flow chart.

View this table:

Patients' baseline characteristics

The mean sellar volume was 962 ± 317 mm³ in the IPT group, 1079 ± 455 mm³ in the IIH group, and 534 ± 118 mm³ for the control group. Patients with IPT and IIH undergoing venous stent placement had significantly higher sellar volumes than the control group (P < .001). There was no difference in the sellar volumes between IPT and IIH groups (P = .63) (Fig 3). The intraclass correlation coefficient was 0.782 for sellar volumes between the independent reviewers.

Fig 3.

Estimated sellar volumes (cubic millimeters) based on preoperative CTA measurements for patients with isolated venous pulsatile tinnitus and idiopathic intracranial hypertension.

The mean ratio of GH/SH was 0.436 ± 0.21 for the IPT group and 0.375 ± 0.18 for the IIH group (P = .25). There was a trend toward higher trans-stenotic gradients for the IIH group (mean, 11.3 ± 6.1 mm Hg) compared with the IPT group (mean, 8.9 ± 5.4 mm Hg) (P = .07), as depicted in Fig 4. The ANCOVA showed no association between sellar volumes or GH/SH and age, sex, trans-stenotic gradients, BMI, or the type of venous stenosis.

Fig 4.

Trans-stenotic gradients (millimeters of mercury) based on local anesthesia venous manometry measurements for patients with isolated venous pulsatile tinnitus and IIH.

DISCUSSION

In the current study, we found that the sellar volumes and heights were significantly higher in patients with symptomatic lateral sinus stenosis compared with a sample of control subjects. There was no significant difference in sellar volumes or GH/SH between patients with IPT and IIH. These findings suggest that an empty sella is found in 2 differing groups of patients, both benefiting from venous sinus stent placement. To our knowledge, the sellar characteristics of patients with IPT, but not satisfying the Dandy criteria, have not previously been reported or compared with patients with elevated intracranial pressure and with control subjects. An empty or partially empty sella has been reported in patients with both IPT and no elevated intracranial pressure²³ and patients with IIH.²⁴ Patients with IIH can present with IPT,²⁵ and venous sinus stenosis has been observed and treated in both instances.^26,27 However, an empty sella is less commonly observed in other causes of chronic elevation of intracranial pressure or after venous thrombosis.^28,29 Eisenman et al³⁰ also observed a high rate of empty sella and transverse sinus stenosis in a series of 40 patients presenting with pulsatile tinnitus who underwent transtemporal surgical reconstruction of sigmoid sinus wall anomalies.

On the basis of our results, we suggest that the arachnoidocele of the sella is not the consequence of an elevation of the intracranial pressure but rather a consequence of a disorder of CSF resorption following the elevation of venous pressure.

The potential mechanism of pulsatile tinnitus in the context of a cerebral venous sinus stenosis with a significant trans-stenotic gradient has been previously discussed.^18,30 Flow turbulence secondary to acceleration through the stenosis, combined with the rhythmicity of the additional compression during the systole of venous structures in the vicinity of the inner ear, is hypothesized to explain the pulsatile nature of the tinnitus.

On the other hand, the physiopathology of IIH may be complex, and proposed mechanisms remain to be demonstrated. The default in CSF reabsorption at the arachnoid granulations of the superior sagittal sinus is increasingly being linked to an increased endoluminal pressure in the superior sagittal sinus in the context of hemodynamic stenosis.³¹

Various theories have been suggested to explain the physiopathology of the empty sella: congenital absence or insufficiency of the diaphragm sellae, induced enlargement of the bony sellar compartment, or necrosis of a previous pituitary adenoma.^32⇓–34 More recent work on animal models of CSF turnover pointed out the role of cervical lymphatics.^35⇓–37 CSF that is not reabsorbed through arachnoid granulations at the superior sagittal sinus may reach the cervical lymphatics by tracking along the cranial nerves³⁸ or the Virchow-Robin spaces.³⁹ Increased CSF spaces and infiltration of the sella may occur once these compensatory mechanisms are exceeded, and this may explain the radiologic findings in patients with venous sinus stenosis, including an empty sella syndrome.

We propose that enlarged CSF spaces found in patients with either intracranial hypertension or pulsatile tinnitus are the consequence of a common mechanism—a hemodynamic venous sinus stenosis. The hemodynamic stenosis of the lateral sinuses would, therefore, be a pathologic entity in itself, leading to a disruption of the CSF drainage at the origin of specific radiologic signs of this entity, regardless of the intracranial pressure. We would propose a new name for this entity: “symptomatic lateral sinus stenosis.” Levitt et al²⁰ reported the results of 9 patients without IIH who underwent venous stent placement and grouped them under the terminology “symptomatic venous sinus stenosis.” Demonstration of causality remains, however, beyond the scope of the current study.

The reason that some patients with lateral sinus stenosis go on to develop isolated IPT versus IIH remains unclear. We did not find a significant correlation among age, sex, and the type of sinus stenosis. In the current study, we observed a trend to indicate a graded clinical spectrum for symptomatic cerebral venous sinus stenosis. Our study was not primarily designed to and lacks the power to study explanatory variables for the difference between patients with IIH and IPT. Obesity, hormonal factors, brain volumes, associated venous sinus anomalies, and reversibility of the enlarged sella would be additional variables to explore in future research. We elected to exclude patients with associated sigmoid sinus wall anomalies in the current study because endovascular therapy can also be effective in dealing with this etiology of pulsatile tinnitus.¹⁹

One of the limitations of our study lies in its retrospective nature. Discrimination between patients with IIH and IPT relied on retrospective chart review and on chart annotation or lumbar puncture opening pressures, ophthalmologic assessments, and clinical histories. However, the main outcome was based on prospectively collected radiologic data by 2 independent reviewers. Because lumbar puncture is not part of our routine work-up for patients with IPT, it is possible that some patients in this group had an unrecognized intracranial hypertension. Lumbar puncture was performed in the first 2 patients with IPT considered for venous stent placement. Neither had headache, papilledema, nor sixth cranial nerve palsy. The opening pressures were, respectively, 14 and 16 cm H₂O. Both patients developed a cerebral hypotension syndrome following the lumbar puncture and required a blood patch.

We considered, at that time, that submitting the IPT group to lumbar punctures strictly for academic purposes was unethical, though this choice limits interpretation of the current study. We have since restricted the lumbar punctures to the group of patients presenting with papilledema or otherwise suspected of having IIH. Future research should consider lumbar puncture in patients with IPT as long as the ethical aspects have been debated. Even though MR imaging with a sella turcica protocol would have provided a more accurate estimation of sellar volumes, we elected to use the CTA performed in our institution to help standardize the measurements. We did not repeat an MR imaging at our institution for patients who already had one in another center. Dedicated sella turcica sequences were, therefore, not available for all patients. This method may overestimate the volume of CSF in the sella turcica, but we were more interested in the relative value of sellar volumes among the 3 samples of subjects than the absolute value. Moreover, the intraclass coefficient was good between the 2 reviewers. The accuracy of volume estimation may also have been limited by the differing sellar shapes. Software calculation may be considered in future work. We did not look at the reversibility of the sinus stenosis after treatment. Controversy surrounding the cause-and-effect relationship of venous stenosis and elevated intracranial pressure^{40⇓⇓–43} should, nevertheless, be explored in future research.

CONCLUSIONS

The current study supports our hypothesis that sellar volumes are comparable in between patients treated for a symptomatic venous sinus stenosis and are larger than in a control group. We suggest that the empty sella is a radiologic sign of hemodynamic lateral sinus stenosis rather than elevated intracranial pressure. Various clinical presentations may thus be regrouped under a new clinical entity: the symptomatic lateral sinus stenosis. Future research should prospectively look at the long-term radiologic and clinical outcomes of untreated or asymptomatic patients with a lateral sinus stenosis. The concept of a clinical spectrum for symptomatic cerebral venous stenosis may be explored by studying factors that may differentiate IIH from IPT.

References

1.↵
2. Naing S,
3. Frohman LA
. The empty sella. Pediatr Endocrinol Rev 2007;4:335–42 pmid:17643081
PubMed
2.↵
2. Davis S,
3. Tress B,
4. King J
. Primary empty sella syndrome and benign intracranial hypertension. Clin Exp Neurol 1978;15:248–57 pmid:756018
PubMed
3.↵
2. Bidot S,
3. Saindane AM,
4. Peragallo JH, et al
. Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmology 2015;35:400–11 doi:10.1097/WNO.0000000000000303 pmid:26457687
CrossRef PubMed
4.↵
2. Agid R,
3. Farb RI,
4. Willinsky RA, et al
. Idiopathic intracranial hypertension: The validity of cross-sectional neuroimaging signs. Neuroradiology 2006;48:521–27 doi:10.1007/s00234-006-0095-y pmid:16703359
CrossRef PubMed
5.↵
2. Brodsky MC,
3. Vaphiades M
. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998;105:1686–93 doi:10.1016/S0161-6420(98)99039-X pmid:9754178
CrossRef PubMed
6.↵
2. de Vries-Knoppert WA
. Primary empty sella syndrome and benign intracranial hypertension. Doc Ophthalmol 1986;61:319–25 pmid:3948665
CrossRef PubMed
7.↵
2. Foley KM,
3. Posner JB
. Does pseudotumor cerebri cause the empty sella syndrome? Neurology 1975;25:565–69 doi:10.1212/wnl.25.6.565 pmid:1168876
Abstract/FREE Full Text
8.↵
2. Degnan AJ,
3. Levy LM
. Pseudotumor cerebri: brief review of clinical syndrome and imaging findings. AJNR Am J Neuroradiol 2011;32:1986–93 doi:10.3174/ajnr.A2404 pmid:21680652
Abstract/FREE Full Text
9.↵
2. Rohr AC,
3. Riedel C,
4. Fruehauf MC, et al
. MR imaging findings in patients with secondary intracranial hypertension. AJNR Am J Neuroradiol 2011;32:1021–29 doi:10.3174/ajnr.A2463 pmid:21511864
Abstract/FREE Full Text
10.↵
2. Ahmed RM,
3. Wilkinson M,
4. Parker GD, et al
. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 2011;32:1408–14 doi:10.3174/ajnr.A2575 pmid:21799038
Abstract/FREE Full Text
11.↵
2. Higgins JNP,
3. Owler BK,
4. Cousins C, et al
. Venous sinus stenting for refractory benign intracranial hypertension. Lancet 2002;359:228–30 doi:10.1016/S0140-6736(02)07440-8 pmid:11812561
CrossRef PubMed
12.↵
2. Dinkin MJ,
3. Patsalides A
. Venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2017;37:113–21 doi:10.1097/WNO.0000000000000426 pmid:27556959
CrossRef PubMed
13.↵
2. Sismanis A
. Otologic manifestations of benign intracranial hypertension syndrome: diagnosis and management. Laryngoscope 1987;97:1–17 doi:10.1288/00005537-198708001-00001 pmid:27556959
CrossRef PubMed
14.↵
2. Reardon MA,
3. Raghavan P
. Venous abnormalities leading to tinnitus: imaging evaluation. Neuroimaging Clin N Am 2016;26:237–45 doi:10.1016/j.nic.2015.12.006 pmid:27154606
CrossRef PubMed
15.↵
2. Dong C,
3. Zhao PF,
4. Yang JG, et al
. Incidence of vascular anomalies and variants associated with unilateral venous pulsatile tinnitus in 242 patients based on dual-phase contrast-enhanced computed tomography. Chin Med J (Engl) 2015;128:581–85 doi:10.4103/0366-6999.151648 pmid:25698187
CrossRef PubMed
16.↵
2. Dietz RR,
3. Davis WL,
4. Harnsberger HR, et al
. MR imaging and MR angiography in the evaluation of pulsatile tinnitus. AJNR Am J Neuroradiol 1994;15:879–89 pmid:8059655
Abstract/FREE Full Text
17.↵
2. Krishnan A,
3. Mattox DE,
4. Fountain AJ, et al
. CT arteriography and venography in pulsatile tinnitus: preliminary results. AJNR Am J Neuroradiol 2006;27:1635–68 pmid:16971601
Abstract/FREE Full Text
18.↵
2. Lenck S,
3. Labeyrie MA,
4. Vallee F, et al
. Stent placement for disabling pulsatile tinnitus caused by a lateral sinus stenosis: a retrospective study. Oper Neurosurg (Hagerstown) 2017;13:560–65 doi:10.1093/ons/opx026 pmid:28922875
CrossRef PubMed
19.↵
2. Yang I-H,
3. Pereira VM,
4. Lenck S, et al
. Endovascular treatment of debilitating tinnitus secondary to cerebral venous sinus abnormalities: a literature review and technical illustration. J Neurointerv Surg 2019;11:841–46 doi:10.1136/neurintsurg-2019-014725 pmid:30872352
Abstract/FREE Full Text
20.↵
2. Levitt MR,
3. Albuquerque FC,
4. Gross BA, et al
. Venous sinus stenting in patients without idiopathic intracranial hypertension. J Neurointerv Surg 2017;9:512–15 doi:10.1136/neurintsurg-2016-012405 pmid:27199383
Abstract/FREE Full Text
21.↵
2. Smith JL
. Whence pseudotumor cerebri? J Clin Neuroophthalmol 1985;5:55–66 pmid:3156890
PubMed
22.↵
2. Lenck S,
3. Vallée F,
4. Labeyrie M-A, et al
. Stenting of the lateral sinus in idiopathic intracranial hypertension according to the type of stenosis. Neurosurgery 2017;80:393–400 doi:10.1227/NEU.0000000000001261 pmid:27218234
CrossRef PubMed
23.↵
2. Weissman JL,
3. Hirsch BE
. Imaging of tinnitus: a review. Radiology 2000;216:342–49 pmid:10924551
CrossRef PubMed
24.↵
2. Silbergleit R,
3. Junck L,
4. Gebarski SS, et al
. Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging. Radiology 1989;170:207–09 doi:10.1148/radiology.170.1.2909098 pmid:2909098
CrossRef PubMed
25.↵
2. Sismanis A,
3. Butts FM,
4. Hughes GB
. Objective tinnitus in benign intracranial hypertension: an update. Laryngoscope 1990;100:33–36 doi:10.1288/00005537-199001000-00008 pmid:2293699
CrossRef PubMed
26.↵
2. Bracard S,
3. Schmitt E,
4. Klein O, et al
. “Benign” intracranial hypertension: neuroradiology and endovascular treatments (in French). Neurochirurgie 2008;54:721–73 doi:10.1016/j.neuchi.2008.10.005 pmid:19004460
CrossRef PubMed
27.↵
2. Puffer RC,
3. Mustafa W,
4. Lanzino G
. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg 2013;5:483–86 doi:10.1136/neurintsurg-2012-010468 pmid:22863980
Abstract/FREE Full Text
28.↵
2. Kesavadas C,
3. Thomas B,
4. Kapilamoorthy T, et al
. Imaging signs in idiopathic intracranial hypertension: are these signs seen in secondary intracranial hypertension too? Ann Indian Acad Neurol 2013;16:229 doi:10.4103/0972-2327.112476 pmid:23956571
CrossRef PubMed
29.↵
2. Ridha MA,
3. Saindane AM,
4. Bruce BB, et al
. Magnetic resonance imaging findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis. Neuroophthalmology 2013;37:1–6 doi:10.3109/01658107.2012.738759 pmid:24019557
CrossRef PubMed
30.↵
2. Eisenman DJ,
3. Raghavan P,
4. Hertzano R, et al
. Evaluation and treatment of pulsatile tinnitus associated with sigmoid sinus wall anomalies. Laryngoscope 2018;128:S1–13 doi:10.1002/lary.27218 pmid:29756346
CrossRef PubMed
31.↵
2. Markey KA,
3. Mollan SP,
4. Jensen RH, et al
. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 2016;15:78–91 doi:10.1016/S1474-4422(15)00298-7 pmid:26700907
CrossRef PubMed
32.↵
2. Weisberg LA,
3. Housepian EM,
4. Saur DP
. Empty sella syndrome as complication of benign intracranial hypertension. J Neurosurg 1975;43:177–80 doi:10.3171/jns.1975.43.2.0177 pmid:1185249
CrossRef PubMed
33.↵
2. Kyung SE,
3. Botelho JV,
4. Horton JC
. Enlargement of the sella turcica in pseudotumor cerebri. J Neurosurg 2014;120:538–42 doi:10.3171/2013.10.JNS131265 pmid:24313606
CrossRef PubMed
34.↵
2. Bjerre P
. The empty sella: a reappraisal of etiology and pathogenesis. Acta Neurol Scand, Suppl 1990;130:1–25 pmid:2220326
PubMed
35.↵
2. Johnston M,
3. Zakharov A,
4. Papaiconomou C, et al
. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res 2004;1:2 doi:10.1186/1743-8454-1-2 pmid:15679948
CrossRef PubMed
36.↵
2. Brinker T,
3. Stopa E,
4. Morrison J, et al
. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 2014;11:10 doi:10.1186/2045-8118-11-10 pmid:24817998
CrossRef PubMed
37.↵
2. Bulat M,
3. Klarica M
. Recent insights into a new hydrodynamics of the cerebrospinal fluid. Brain Res Rev 2011;65:99–112 doi:10.1016/j.brainresrev.2010.08.002 pmid:20817024
CrossRef PubMed
38.↵
2. McComb JG
. Recent research into the nature of cerebrospinal fluid formation and absorption. J Neurosurg 1983;59:369–83 doi:10.3171/jns.1983.59.3.0369 pmid:6886750
CrossRef PubMed
39.↵
2. Cherian I,
3. Beltran M,
4. Kasper E, et al
. Exploring the Virchow-Robin spaces function: a unified theory of brain diseases. Surg Neurol Int 2016;7(Suppl 26):S711–14 doi:10.4103/2152-7806.192486 pmid:27857861
CrossRef PubMed
40.↵
2. Bateman GA
. Stenoses in idiopathic intracranial hypertension: to stent or not to stent? AJNR Am J Neuroradiol 2008;29:215 doi:10.3174/ajnr.A0804 pmid:18272567
FREE Full Text
41.↵
2. Fraser JA,
3. Leung AE
. Reversibility of MRI features of pseudotumor cerebri syndrome. Can J Neurol Sci 2014;41:530–32 pmid:24878485
CrossRef PubMed
42.↵
2. Rohr A,
3. Dörner L,
4. Stingele R, et al
. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007;28:656–59 pmid:17416816
Abstract/FREE Full Text
43.↵
2. De Simone R,
3. Ranieri A,
4. Montella S, et al
. The role of dural sinus stenosis in idiopathic intracranial hypertension pathogenesis: the self-limiting venous collapse feedback-loop model. Panminerva Med 2014;56:201–09 pmid:24867405
PubMed

Received April 11, 2019.
Accepted after revision August 1, 2019.

View Abstract

In this issue

Download PDF

Email Article

Citation Tools

Purchase

Cited By...

Dural Venous Sinus Stenosis: Why Distinguishing Intrinsic-versus-Extrinsic Stenosis Matters

More in this TOC Section

Show more ADULT BRAIN

[1] 1.↵

Naing S,
Frohman LA
. The empty sella. Pediatr Endocrinol Rev 2007;4:335–42 pmid:17643081
PubMed

[3] Naing S,

[4] Frohman LA

[5] 2.↵

Davis S,
Tress B,
King J
. Primary empty sella syndrome and benign intracranial hypertension. Clin Exp Neurol 1978;15:248–57 pmid:756018
PubMed

[7] Davis S,

[8] Tress B,

[9] King J

[10] 3.↵

Bidot S,
Saindane AM,
Peragallo JH, et al
. Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmology 2015;35:400–11 doi:10.1097/WNO.0000000000000303 pmid:26457687
CrossRef PubMed

[12] Bidot S,

[13] Saindane AM,

[14] Peragallo JH, et al

[15] 4.↵

Agid R,
Farb RI,
Willinsky RA, et al
. Idiopathic intracranial hypertension: The validity of cross-sectional neuroimaging signs. Neuroradiology 2006;48:521–27 doi:10.1007/s00234-006-0095-y pmid:16703359
CrossRef PubMed

[17] Agid R,

[18] Farb RI,

[19] Willinsky RA, et al

[20] 5.↵

Brodsky MC,
Vaphiades M
. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998;105:1686–93 doi:10.1016/S0161-6420(98)99039-X pmid:9754178
CrossRef PubMed

[22] Brodsky MC,

[23] Vaphiades M

[24] 6.↵

de Vries-Knoppert WA
. Primary empty sella syndrome and benign intracranial hypertension. Doc Ophthalmol 1986;61:319–25 pmid:3948665
CrossRef PubMed

[26] de Vries-Knoppert WA

[27] 7.↵

Foley KM,
Posner JB
. Does pseudotumor cerebri cause the empty sella syndrome? Neurology 1975;25:565–69 doi:10.1212/wnl.25.6.565 pmid:1168876
Abstract/FREE Full Text

[29] Foley KM,

[30] Posner JB

[31] 8.↵

Degnan AJ,
Levy LM
. Pseudotumor cerebri: brief review of clinical syndrome and imaging findings. AJNR Am J Neuroradiol 2011;32:1986–93 doi:10.3174/ajnr.A2404 pmid:21680652
Abstract/FREE Full Text

[33] Degnan AJ,

[34] Levy LM

[35] 9.↵

Rohr AC,
Riedel C,
Fruehauf MC, et al
. MR imaging findings in patients with secondary intracranial hypertension. AJNR Am J Neuroradiol 2011;32:1021–29 doi:10.3174/ajnr.A2463 pmid:21511864
Abstract/FREE Full Text

[37] Rohr AC,

[38] Riedel C,

[39] Fruehauf MC, et al

[40] 10.↵

Ahmed RM,
Wilkinson M,
Parker GD, et al
. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 2011;32:1408–14 doi:10.3174/ajnr.A2575 pmid:21799038
Abstract/FREE Full Text

[42] Ahmed RM,

[43] Wilkinson M,

[44] Parker GD, et al

[45] 11.↵

Higgins JNP,
Owler BK,
Cousins C, et al
. Venous sinus stenting for refractory benign intracranial hypertension. Lancet 2002;359:228–30 doi:10.1016/S0140-6736(02)07440-8 pmid:11812561
CrossRef PubMed

[47] Higgins JNP,

[48] Owler BK,

[49] Cousins C, et al

[50] 12.↵

Dinkin MJ,
Patsalides A
. Venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2017;37:113–21 doi:10.1097/WNO.0000000000000426 pmid:27556959
CrossRef PubMed

[52] Dinkin MJ,

[53] Patsalides A

[54] 13.↵

Sismanis A
. Otologic manifestations of benign intracranial hypertension syndrome: diagnosis and management. Laryngoscope 1987;97:1–17 doi:10.1288/00005537-198708001-00001 pmid:27556959
CrossRef PubMed

[56] Sismanis A

[57] 14.↵

Reardon MA,
Raghavan P
. Venous abnormalities leading to tinnitus: imaging evaluation. Neuroimaging Clin N Am 2016;26:237–45 doi:10.1016/j.nic.2015.12.006 pmid:27154606
CrossRef PubMed

[59] Reardon MA,

[60] Raghavan P

[61] 15.↵

Dong C,
Zhao PF,
Yang JG, et al
. Incidence of vascular anomalies and variants associated with unilateral venous pulsatile tinnitus in 242 patients based on dual-phase contrast-enhanced computed tomography. Chin Med J (Engl) 2015;128:581–85 doi:10.4103/0366-6999.151648 pmid:25698187
CrossRef PubMed

[63] Dong C,

[64] Zhao PF,

[65] Yang JG, et al

[66] 16.↵

Dietz RR,
Davis WL,
Harnsberger HR, et al
. MR imaging and MR angiography in the evaluation of pulsatile tinnitus. AJNR Am J Neuroradiol 1994;15:879–89 pmid:8059655
Abstract/FREE Full Text

[68] Dietz RR,

[69] Davis WL,

[70] Harnsberger HR, et al

[71] 17.↵

Krishnan A,
Mattox DE,
Fountain AJ, et al
. CT arteriography and venography in pulsatile tinnitus: preliminary results. AJNR Am J Neuroradiol 2006;27:1635–68 pmid:16971601
Abstract/FREE Full Text

[73] Krishnan A,

[74] Mattox DE,

[75] Fountain AJ, et al

[76] 18.↵

Lenck S,
Labeyrie MA,
Vallee F, et al
. Stent placement for disabling pulsatile tinnitus caused by a lateral sinus stenosis: a retrospective study. Oper Neurosurg (Hagerstown) 2017;13:560–65 doi:10.1093/ons/opx026 pmid:28922875
CrossRef PubMed

[78] Lenck S,

[79] Labeyrie MA,

[80] Vallee F, et al

[81] 19.↵

Yang I-H,
Pereira VM,
Lenck S, et al
. Endovascular treatment of debilitating tinnitus secondary to cerebral venous sinus abnormalities: a literature review and technical illustration. J Neurointerv Surg 2019;11:841–46 doi:10.1136/neurintsurg-2019-014725 pmid:30872352
Abstract/FREE Full Text

[83] Yang I-H,

[84] Pereira VM,

[85] Lenck S, et al

[86] 20.↵

Levitt MR,
Albuquerque FC,
Gross BA, et al
. Venous sinus stenting in patients without idiopathic intracranial hypertension. J Neurointerv Surg 2017;9:512–15 doi:10.1136/neurintsurg-2016-012405 pmid:27199383
Abstract/FREE Full Text

[88] Levitt MR,

[89] Albuquerque FC,

[90] Gross BA, et al

[91] 21.↵

Smith JL
. Whence pseudotumor cerebri? J Clin Neuroophthalmol 1985;5:55–66 pmid:3156890
PubMed

[93] Smith JL

[94] 22.↵

Lenck S,
Vallée F,
Labeyrie M-A, et al
. Stenting of the lateral sinus in idiopathic intracranial hypertension according to the type of stenosis. Neurosurgery 2017;80:393–400 doi:10.1227/NEU.0000000000001261 pmid:27218234
CrossRef PubMed

[96] Lenck S,

[97] Vallée F,

[98] Labeyrie M-A, et al

[99] 23.↵

Weissman JL,
Hirsch BE
. Imaging of tinnitus: a review. Radiology 2000;216:342–49 pmid:10924551
CrossRef PubMed

[101] Weissman JL,

[102] Hirsch BE

[103] 24.↵

Silbergleit R,
Junck L,
Gebarski SS, et al
. Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging. Radiology 1989;170:207–09 doi:10.1148/radiology.170.1.2909098 pmid:2909098
CrossRef PubMed

[105] Silbergleit R,

[106] Junck L,

[107] Gebarski SS, et al

[108] 25.↵

Sismanis A,
Butts FM,
Hughes GB
. Objective tinnitus in benign intracranial hypertension: an update. Laryngoscope 1990;100:33–36 doi:10.1288/00005537-199001000-00008 pmid:2293699
CrossRef PubMed

[110] Sismanis A,

[111] Butts FM,

[112] Hughes GB

[113] 26.↵

Bracard S,
Schmitt E,
Klein O, et al
. “Benign” intracranial hypertension: neuroradiology and endovascular treatments (in French). Neurochirurgie 2008;54:721–73 doi:10.1016/j.neuchi.2008.10.005 pmid:19004460
CrossRef PubMed

[115] Bracard S,

[116] Schmitt E,

[117] Klein O, et al

[118] 27.↵

Puffer RC,
Mustafa W,
Lanzino G
. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg 2013;5:483–86 doi:10.1136/neurintsurg-2012-010468 pmid:22863980
Abstract/FREE Full Text

[120] Puffer RC,

[121] Mustafa W,

[122] Lanzino G

[123] 28.↵

Kesavadas C,
Thomas B,
Kapilamoorthy T, et al
. Imaging signs in idiopathic intracranial hypertension: are these signs seen in secondary intracranial hypertension too? Ann Indian Acad Neurol 2013;16:229 doi:10.4103/0972-2327.112476 pmid:23956571
CrossRef PubMed

[125] Kesavadas C,

[126] Thomas B,

[127] Kapilamoorthy T, et al

[128] 29.↵

Ridha MA,
Saindane AM,
Bruce BB, et al
. Magnetic resonance imaging findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis. Neuroophthalmology 2013;37:1–6 doi:10.3109/01658107.2012.738759 pmid:24019557
CrossRef PubMed

[130] Ridha MA,

[131] Saindane AM,

[132] Bruce BB, et al

[133] 30.↵

Eisenman DJ,
Raghavan P,
Hertzano R, et al
. Evaluation and treatment of pulsatile tinnitus associated with sigmoid sinus wall anomalies. Laryngoscope 2018;128:S1–13 doi:10.1002/lary.27218 pmid:29756346
CrossRef PubMed

[135] Eisenman DJ,

[136] Raghavan P,

[137] Hertzano R, et al

[138] 31.↵

Markey KA,
Mollan SP,
Jensen RH, et al
. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 2016;15:78–91 doi:10.1016/S1474-4422(15)00298-7 pmid:26700907
CrossRef PubMed

[140] Markey KA,

[141] Mollan SP,

[142] Jensen RH, et al

[143] 32.↵

Weisberg LA,
Housepian EM,
Saur DP
. Empty sella syndrome as complication of benign intracranial hypertension. J Neurosurg 1975;43:177–80 doi:10.3171/jns.1975.43.2.0177 pmid:1185249
CrossRef PubMed

[145] Weisberg LA,

[146] Housepian EM,

[147] Saur DP

[148] 33.↵

Kyung SE,
Botelho JV,
Horton JC
. Enlargement of the sella turcica in pseudotumor cerebri. J Neurosurg 2014;120:538–42 doi:10.3171/2013.10.JNS131265 pmid:24313606
CrossRef PubMed

[150] Kyung SE,

[151] Botelho JV,

[152] Horton JC

[153] 34.↵

Bjerre P
. The empty sella: a reappraisal of etiology and pathogenesis. Acta Neurol Scand, Suppl 1990;130:1–25 pmid:2220326
PubMed

[155] Bjerre P

[156] 35.↵

Johnston M,
Zakharov A,
Papaiconomou C, et al
. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res 2004;1:2 doi:10.1186/1743-8454-1-2 pmid:15679948
CrossRef PubMed

[158] Johnston M,

[159] Zakharov A,

[160] Papaiconomou C, et al

[161] 36.↵

Brinker T,
Stopa E,
Morrison J, et al
. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 2014;11:10 doi:10.1186/2045-8118-11-10 pmid:24817998
CrossRef PubMed

[163] Brinker T,

[164] Stopa E,

[165] Morrison J, et al

[166] 37.↵

Bulat M,
Klarica M
. Recent insights into a new hydrodynamics of the cerebrospinal fluid. Brain Res Rev 2011;65:99–112 doi:10.1016/j.brainresrev.2010.08.002 pmid:20817024
CrossRef PubMed

[168] Bulat M,

[169] Klarica M

[170] 38.↵

McComb JG
. Recent research into the nature of cerebrospinal fluid formation and absorption. J Neurosurg 1983;59:369–83 doi:10.3171/jns.1983.59.3.0369 pmid:6886750
CrossRef PubMed

[172] McComb JG

[173] 39.↵

Cherian I,
Beltran M,
Kasper E, et al
. Exploring the Virchow-Robin spaces function: a unified theory of brain diseases. Surg Neurol Int 2016;7(Suppl 26):S711–14 doi:10.4103/2152-7806.192486 pmid:27857861
CrossRef PubMed

[175] Cherian I,

[176] Beltran M,

[177] Kasper E, et al

[178] 40.↵

Bateman GA
. Stenoses in idiopathic intracranial hypertension: to stent or not to stent? AJNR Am J Neuroradiol 2008;29:215 doi:10.3174/ajnr.A0804 pmid:18272567
FREE Full Text

[180] Bateman GA

[181] 41.↵

Fraser JA,
Leung AE
. Reversibility of MRI features of pseudotumor cerebri syndrome. Can J Neurol Sci 2014;41:530–32 pmid:24878485
CrossRef PubMed

[183] Fraser JA,

[184] Leung AE

[185] 42.↵

Rohr A,
Dörner L,
Stingele R, et al
. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007;28:656–59 pmid:17416816
Abstract/FREE Full Text

[187] Rohr A,

[188] Dörner L,

[189] Stingele R, et al

[190] 43.↵

De Simone R,
Ranieri A,
Montella S, et al
. The role of dural sinus stenosis in idiopathic intracranial hypertension pathogenesis: the self-limiting venous collapse feedback-loop model. Panminerva Med 2014;56:201–09 pmid:24867405
PubMed

[192] De Simone R,

[193] Ranieri A,

[194] Montella S, et al

Main menu

User menu

Search

American Journal of Neuroradiology

Empty Sella Is a Sign of Symptomatic Lateral Sinus Stenosis and Not Intracranial Hypertension

Abstract

ABBREVIATIONS:

MATERIALS AND METHODS

Study Population

Data Collection

Diagnosis and Treatment

Data Analysis

RESULTS

DISCUSSION

CONCLUSIONS

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology

Main menu

User menu

Search

Empty Sella Is a Sign of Symptomatic Lateral Sinus Stenosis and Not Intracranial Hypertension

Abstract

ABBREVIATIONS:

MATERIALS AND METHODS

Study Population

Data Collection

Diagnosis and Treatment

Data Analysis

RESULTS

DISCUSSION

CONCLUSIONS

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology